News

Applications are now open for the European Diploma in HIV Medicine examination!

The examination is designed for practising medical professionals working in HIV care and aims to support the harmonisation of clinical practice across Europe, while addressing the need for a recognised specialisation in HIV medicine within postgraduate training. By acknowledging differences in practice between countries, the Diploma helps define minimum standards for education and training and ensures practitioners have the core knowledge, skills and competencies required for effective HIV care.

Key dates for the 2026 examination

• Examination date: 25 September 2026
• Application deadline: 12 August 2026

The examination uses Single Best Answer questions to assess competence in HIV management and offers clinicians the opportunity to demonstrate clinical proficiency through certification, benchmark their knowledge against European standards, support continued professional development and strengthen professional mobility within HIV care.

Aligned with a shared European curriculum and the latest developments in HIV medicine, the Diploma supports continued learning, professional growth and improved patient outcomes.

Learn more and apply!

Europe has the tools and knowledge to end HIV as a public health threat, yet progress is stalling and, in some areas, reversing. New HIV acquisitions and AIDS related deaths are rising, inequalities persist across and within Member States, and agreed targets remain out of reach. At the same time, community led organisations that are central to prevention, testing, treatment access and human rights are being weakened by shrinking funding and declining policy attention.

EACS – as a member of the Coalition for a European HIV Response alongside the International AIDS Society (IAS) and community organisations from across Europe – support this joint statement as a call for urgent political action.

It sets out why the current trajectory is not inevitable but the result of policy choices, and urges the European Parliament, the European Commission and Member States to renew leadership, secure predictable and sustainable investment, and place community leadership at the heart of Europe’s HIV response, in the EU and globally.

Read the full statement and sign it today!

EACS is looking for a Project Coordinator to join its team in Brussels.

This role combines event coordination, stakeholder engagement, and digital learning, including work on the European AIDS Conference and the EACS eAcademy.

The position is based in Brussels (hybrid, with regular presence in the office) and is offered as a full-time, permanent Belgian contract.

Applicants must be based in Belgium and have the right to work in Belgium.

Learn more about the position and apply!

A new study from experts within EACS analyses the first ~100 reported cases of virological failure with long-acting cabotegravir/rilpivirine (CAB/RPV-LA).

The key takeaway: failure remains rare, but when it occurs it is often associated with emergent resistance, sometimes affecting future treatment options. RPV or CAB levels at failure were often low; however, similar low levels are sometimes also observed in successfully treated individuals, highlighting the complexity of interpreting drug concentrations.

As long-acting antiretroviral therapies become more widely used, continued monitoring of resistance patterns and viral subtypes will be critical.

Congratulations to the authors Maria Mazzitelli, Milosz Parczewski, David Burger, and Annemarie Wensing for this important contribution.

Published in Clinical Infectious Diseases

https://bit.ly/VirologicalFailure  

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag046/8508656?login=false

International Women's Day is an important occasion to highlight women’s health and to recognise the specific needs of women living with or vulnerable to HIV. WAVE continues to bring attention to these issues by supporting research, sharing expertise and working with clinical and community partners across Europe.

To mark this day, Nina Weis, Chair of WAVE, has written an editorial in HIV Medicine. Her piece outlines current priorities in women’s health, including the challenges faced by women who are migrants, the need for clearer guidance on menopause in women with HIV, ongoing gaps in HPV screening, and the importance of improving healthcare experiences for women across Europe. The editorial also reflects on recent work in breastfeeding guidance and continued activities of the WAVE in Ukraine workshop.

Article available here. 

Under the umbrella of the EACS Medical Exchange Programme, SCEP aims at promoting clinical, research and educational links between centres across Europe and facilitating exchange of models of clinical care in HIV medicine and allied specialities.

Fellows will have the opportunity to visit an EACS Clinical/Research Excellence Centre (CREC) specialised in HIV medicine for a period of 2 to 4 weeks. The CREC can also nominate a member of its team for a reciprocal visit for the same period of time and with the same financial rules.

Visit our website for more information on the application process, the eligibility criteria and the list of Clinical/Research Excellence Centres that can be visited.

Applications are open until 26 April 2026.

The HIV Advanced Training Forum is a two-day international course organised on 25-26 March 2026 in Bucharest Romania, through the collaboration of leading academic and clinical institutions across Europe. 

The course is designed to equip early-career healthcare professionals with practical, patient-centered strategies for long-term HIV care.

Learn more and register.

ID and HIV Dialogues 2026 is a leading event organised in Bucharest Romania on 26-28 March 2026, dedicated to excellence in HIV and infectious diseases. Currently at its seventh edition, the conference brings together distinguished European experts and major scientific societies to deliver state-of-the-art updates in HIV prevention and treatment, viral hepatitis, antimicrobial resistance, emerging infections, diagnostics, and vaccination.

​

With high-level keynote lectures, interactive sessions, and strategic dialogue at the intersection of science, clinical practice, and public health, ID and HIV Dialogues stands as a landmark event shaping the future of infectious disease medicine in Romania and beyond.

​

More information here